Modelling relapse in patients with high-risk localised prostate cancer treated randomly in the GETUG 12 phase III trial reveals two populations of relapsing patients

Cécile Vicier, Karim Fizazi, F. Lesaunier et al.|Annals of Oncology|2016

Cited by 0